News I Events I Buyers Guide I Jobs I Courses I

Research Institutes I Companies I Investment I Technology Parks I BioClusters I Products

05.06.2008 Novel Investigational Regimen Combining Radiation Enhancing Agent With Ibritumomab Tiuxetan (Zevalin(R)) Produces High Rate of Complete Responses in Patients With Rituximab-Refractory Follicular Non-Hodgkin's Lymphoma

09.05.2008 Actemra inhibits joint damage and improves physical function of patients with Rheumatoid Arthritis

   A - 63

   B-  70_

   C - 55   

   D-  38_

   E - 34   

_ F - 18_

  G - 26_

  H - 18   

   I  - 33    

_J -  4 _

   K  -13   

   L  -33   

   M -71   

   N  -16   

   O -20   

_ P - 31   

  Q -  7 

  R - 13

  S - 87

  T - 21

  U -   7

  V - 16

  W - 6

  X  - 4

  Y -  2 

  Z -  7

Total:

721 companies